The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders

Nutrition

Volumn 26, Issue 11-12, 2010, Pages 1038-1043

  Gibson, Peter R ^a   Barrett, Jacqueline S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LACTULOSE; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL TRIAL; COLONY FORMING UNIT; DRUG EFFICACY; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GROWTH INHIBITION; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; INTESTINE TRANSIT TIME; LACTOBACILLUS CASEI; MALABSORPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; BACTERIA; BREATH TESTS; DIET; ENTEROBACTERIACEAE; GASTROENTERITIS; HUMANS; IMMUNITY, MUCOSAL; INTESTINE, SMALL; LACTOBACILLACEAE; PROBIOTICS;

BACTERIA (MICROORGANISMS);

EID: 77957815201     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.01.005     Document Type: Review

References (40)

1. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005, 51(Suppl 1):1-22.
2. Gregg C.R. Enteric bacterial flora and bacterial overgrowth syndrome. Semin Gastrointest Dis 2002, 13:200-209.
3. Sherman P., Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987, 5:157-171.
4. Singh V.V., Toskes P.P. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol 2004, 7:19-28.
5. Bouhnik Y., Alain S., Attar A., Flourié B., Raskine L., Sanson-Le Pors M.J., et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999, 94:1327-1331.
6. Marchesi J., Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis 2007, 20:508-513.
7. Bate J.P., Irving P.M., Barrett J.S., Gibson P.R. Benefits of breath hydrogen testing following lactulose administration in analyzing carbohydrate malabsorption. Eur J Gastroenterol Hepatol 2010, 22:318-326.
8. Strocchi A., Levitt M.D. Maintaining intestinal H2 balance: credit the colonic bacteria. Gastroenterology 1992, 102:1424-1426.
9. Christl S.U., Murgatroyd P.R., Gibson G.R., Cummings J.H. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992, 102:1269-1277.
10. Gibson G.R., Cummings J.H., Macfarlane G.T., Allison C., Segal I., Vorster H.H., et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 1990, 31:679-683.
11. Pimentel M., Lin H.C., Enayati P., van den Burg B., Lee H.R., Chen J.H., et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol 2006, 290:G1089-G1095.
12. Rana S.V., Bhardwaj S.B. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008, 43:1030-1037.
13. Khoshini R., Dai S.-C., Lezcano S., Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008, 53:1443-1454.
14. Riordan S.M., McIver C.J., Walker B.M., Duncombe V.M., Bolin T.D., Thomas M.C. Bacteriological method for detecting small intestinal hypomotility. Am J Gastroenterol 1996, 91:2399-2405.
15. Riordan S.M., McIver C.J., Walker B.M., Duncombe V.M., Bolin T.D., Thomas M.C. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996, 91:1795-1803.
16. Bond J.H., Levitt M.D. The pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest 1972, 51:1219-1225.
17. Pimentel M., Chow E.J., Lin H.C. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003, 98:412-419.
18. Barrett J.S., Irving P.M., Shepherd S.J., Muir J.G., Gibson P.R. Prevalence of fructose and lactose malabsorption in patients with gastrointestinal disorders. Aliment Pharmacol Ther 2009, 30:165-174.
19. Bratten J.R., Spanier J., Jones M.P. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008, 103:958-963.
20. 14C-d-xylose and healthy controls. Am J Gastroenterol 2005, 100:1566-1570.
21. Posserud I., Stotzer P.O., Bjornsson E.S., Abrahamsson H., Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56:802-808.
22. Skoog S.M., Bharucha A.E., Zinsmeister A.R. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS. Neurogastroenterol Motil 2008, 20:505-511.
23. Gibson P.R., Newnham E., Barrett J.S., Shepherd S.J., Muir J.G. Fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007, 25:349-363.
24. Mathias J.R., Clench M.H. Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine. Am J Med Sci 1985, 289:243-248.
25. Nucera G., Gabrielli M., Lupascu A., Lauritano E.C., Santoliquido A., Cremonini F., et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005, 21:1391-1395.
26. Pimentel M., Kong Y., Park S. Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol 2003, 98:2700-2704.
27. Wedlake L., Thomas K., McGough C., Andreyev H.J. Small bowel bacterial overgrowth and lactose intolerances during radical pelvic radiotherapy: an observational study. Eur J Cancer 2008, 44:2212-2217.
28. Cloarec D., Bornet F., Gouilloud S., Barry J.L., Salim B., Galmiche J.P. Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status. Gut 1990, 31:300-304.
29. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973, 14:125-132.
30. Shepherd S.J., Gibson P.R. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Americ Diet Ass 2006, 106:1631-1639.
31. Shepherd S.J., Parker S.C., Muir J.G., Gibson P.R. Randomised, placebo-controlled evidence of dietary triggers for abdominal symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008, 6:765-771.
32. Barbara G., Stanghellini V., Brandi G., Cremon C., Di Nardo G., De Giorgio R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005, 100:2560-2568.
33. Grover M., Kanazawa M., Plasson O.S., Chitkara D.K., Gangarosa L.M., Drossman D.A., et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological stress. Neurogastroenterol Motil 2008, 20:998-1008.
34. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 2008, 57:1315-1321.
35. Pimentel M., Constantino T., Kong Y., Bajwa M., Rezaei A., Park S.A. 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci 2004, 49:73-77.
36. Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008, 28:385-396.
37. Ong D.K., Mitchell S.B., Smith S., Muir J., Barrett J., Shepherd S., et al. The intestinal fermentative response to dietary FODMAPs: failure to switch to methane production in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2008, 23(Suppl 4):A219.
38. Barrett J.S., Canale K.E.K., Gearry R.B., Irving P.M., Gibson P.R. The effect of Lactobacillus casei strain Shirota (Yakult®) on intestinal fermentation patterns in patients with irritable bowel syndrome with an early breath hydrogen rise after lactulose-a proof of concept study. World J Gastroenterol 2008, 14:5020-5024.
39. Gabriella M., Lauritano E.C., Scarpellini E., Lupascu A., Ojetti V., Gasbarrini G., et al. Bacillus clausii as a treatment of small intestinal bacterial overgrowth. Am J Gastroenerol 2009, 104:1327-1328.
40. Schiffrin E.J., Parlesak A., Bode C., Bode J.C., van't Hof M.A., Grathwohl D., et al. Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Br J Nutr 2009, 101:961-966.